Identification of a functional mutation in pp32r1 (ANP32C)

Human Mutation

Volumn 23, Issue 6, 2004, Pages 546-551

  Kochevar, G John ^a   Brody, Jonathan R ^b   Kadkol, ShriHari S ^b   Murphy, Kathleen M ^b   Pasternack, Gary R ^b  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ANP32C; Cancer; Mutation; PC; pp32; pp32r1; Proliferation; Prostate cancer

Indexed keywords

GENE PRODUCT; HISTONE; PROTEIN PP32R1; UNCLASSIFIED DRUG;

ACETYLATION; ANP32 GENE; ANP32C GENE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FIBROBLAST CULTURE; GENE; GENE MUTATION; GENETIC TRANSFECTION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; MOUTH LESION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; RNA STABILITY; TOBACCO; TUMOR CELL LINE;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; CLONING, MOLECULAR; GENE EXPRESSION; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PHOSPHOPROTEINS; POINT MUTATION; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; TRANSFECTION;

NICOTIANA TABACUM;

EID: 2642512486     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.20030     Document Type: Article

References (12)

1. Bai J, Brody JR, Kadkol SS, Pasternack GR. 2001. Tumor suppression and potentiation by manipulation of pp32 expression. Oncogene 20:2153-2160.
2. Beresford PJ, Zhang D, Oh DY, Fan Z, Greer EL, Russo ML, Jaju M, Lieberman J. 2001. Granzyme A activates an endoplasmic reticulum-associated caspase-independent nuclease to induce single-stranded DNA nicks. J Biol Chem 276:43285-43193.
3. Brennan CM, Gallouzi IE, Steitz JA. 2000. Protein ligands to HuR modulate its interaction with target mRNAs in vivo. J Cell Biol 151:1-14.
4. Brody JR, Kadkol SS, Mahmoud MA, Rebel JM, Pasternack GR. 1999. Identification of sequences required for inhibition of oncogene-mediated transformation by pp32. J Biol Chem 274:20053-20055.
5. Jiang X, Kim HE, Shu H, Zhao Y, Zhang H, Kofron J, Donnelly J, Burns D, Ng SC, Rosenberg S, Wang X. 2003. Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Science 299:223-226.
6. Kadkol SS, Brody JR, Epstein JI, Kuhajda FP, Pasternack GR. 1998. Novel nuclear phosphoprotein pp32 is highly expressed in intermediate- and high-grade prostate cancer. Prostate 34:231-237.
7. Kadkol SS, Brody JR, Pevsner J, Bai J, Pasternack GR. 1999. Modulation of oncogenic potential by alternative gene use in human prostate cancer. Nat Med 5:275-279.
8. Kadkol SS, El Naga GA, Brody JR, Bai J, Gusev Y, Dooley WC, Pasternack GR. 2001. Expression of pp32 gene family members in breast cancer. Breast Cancer Res Treat 68:65-73.
9. Li M, Makkinje A, Damuni Z. 1996. Molecular identification of I1PP2A, a novel potent heat-stable inhibitor protein of protein phosphatase 2A. Biochemistry 35:6998-7002.
10. Seo SB, McNamara P, Heo S, Turner A, Lane WS, Chakravarti D. 2001. Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell 104:119-130.
11. Seo SB, Macfarlan T, McNamara P, Hong R, Mukai Y, Heo S, Chakravarti D. 2002. Regulation of histone acetylation and transcription by nuclear protein pp32, a subunit of the INHAT complex. J Biol Chem 277:14005-14010.
12. Yan H, Yuan W, Velculescu VE, Vogelstein B, Kinzler KW. 2002. Allelic variation in human gene expression. Science 297:1143.